Chirality plays critical roles in enhancing the aqueous solubility of nocathiacin i by block copolymer micelles

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 1, 2013, Pages 64-71

  Feng, Kun ^a   Wang, Shuzhen ^a   Ma, Hairong ^a   Chen, Yijun ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

aqueous solubility; block copolymer micelles; chirality; nocathiacin I

Indexed keywords

ANTIBIOTIC AGENT; COPOLYMER; CYMARIN; GENISTIN; METHOXY POLY(ETHYLENE GLYCOL) POLYLACTATE COPOLYMER MICELLE; NOCATHIACIN I; PERUVOSIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CELL STRAIN L 929; CHIRALITY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IN VITRO STUDY; MOUSE; NONHUMAN; OPTICS; PARTICLE SIZE; STEREOCHEMISTRY;

ACTINOMYCETALES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; GLYCOSYLATION; KINETICS; LACTATES; MICE; MICELLES; NANOPARTICLES; PEPTIDES; POLYESTERS; POLYETHYLENE GLYCOLS; PROTEIN STABILITY; SOLUBILITY; STEREOISOMERISM;

EID: 84870915093     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01576.x     Document Type: Article

References (29)

1. Bagley MC, et al,. Thiopeptide antibiotics. Chem Rev 2005; 105: 685-714.
2. Jayasuriya H, et al,. Isolation and structure elucidation of thiazomycin-a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J Antibiot (Tokyo) 2007; 60: 554-564.
3. Li W, et al,. Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. I. Taxonomy, fermentation and biological activities. J Antibiot (Tokyo) 2003; 56: 226-231.
4. Wei M, et al,. A simple reverse genetics approach to elucidating the biosynthetic pathway of nocathiacin. Biotechnol Lett 2011; 33: 585-591.
5. Ding Y, et al,. Moving posttranslational modifications forward to biosynthesize the glycosylated thiopeptide nocathiacin I in Nocardia sp. ATCC202099. Mol Biosyst 2010; 6: 1180-1185.
6. Pucci MJ, et al,. Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics. Antimicrob Agents Chemother 2004; 48: 3697-3701.
7. Naidu BN, et al,. Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Bioorg Med Chem Lett 2006; 16: 3545-3549.
8. Naidu BN, et al,. Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Bioorg Med Chem Lett 2004; 14: 5573-5577.
9. Naidu BN, et al,. Synthesis and antibacterial activity of O-substituted nocathiacin I derivatives. Bioorg Med Chem Lett 2004; 14: 3743-3746.
10. Nicolaou KC, et al,. Construction of substituted N-hydroxyindoles: synthesis of a nocathiacin I model system. Angew Chem Int Ed Engl 2005; 44: 3736-3740.
11. Li W, et al,. N-Demethylation of nocathiacin I via photo-oxidation. Bioorg Med Chem Lett 2008; 18: 4051-4053.
12. Wei M, et al,. Microbial generation of nocathiacin acid from nocathiacin I. Bioresour Technol 2010; 101: 3617-3622.
13. Xu L, et al,. Conversion of nocathiacin I to nocathiacin acid by a mild and selective cleavage of dehydroalanine. J Org Chem 2007; 72: 7447-7450.
14. Kedar U, et al,. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 2010; 6: 714-729.
15. Acharya S, Sahoo SK,. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 2011; 63: 170-183.
16. Jeong B, et al,. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997; 388: 860-862.
17. Xia Y, et al,. Chiral inorganic nanoparticles: origin, optical properties and bioapplications. Nanoscale 2011; 3: 1374-1382.
18. Zhou Y, et al,. Similar topological origin of chiral centers in organic and nanoscale inorganic structures: effect of stabilizer chirality on optical isomerism and growth of CdTe nanocrystals. J Am Chem Soc 2010; 132: 6006-6013.
19. Zhou Y, et al,. Optical coupling between chiral biomolecules and semiconductor nanoparticles: size-dependent circular dichroism absorption. Angew Chem Int Ed Engl 2011; 50: 11456-11459.
20. Li Y, et al,. Chirality of glutathione surface coating affects the cytotoxicity of quantum dots. Angew Chem Int Ed Engl 2011; 50: 5860-5864.
21. Zhu Z, et al,. Manipulation of collective optical activity in one-dimensional plasmonic assembly. ACS Nano 2012; 6: 2326-2332.
22. Zhang X, et al,. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate. Biomaterials 2005; 26: 2121-2128.
23. Zhang W, et al,. Nanomicelle with long-term circulation and enhanced stability of camptothecin based on mPEGylated alpha,beta-poly (L-aspartic acid)-camptothecin conjugate. Colloids Surf B Biointerfaces 2010; 81: 297-303.
24. Kataoka K, et al,. Doxorubicin-loaded poly(ethylene glycol)-poly(beta- benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release 2000; 64: 143-153.
25. Zhou Q, et al,. Preparation and characterization of thermosensitive pluronic F127-b-poly(ε-caprolactone) mixed micelles. Colloids Surf B Biointerfaces 2011; 86: 45-57.
26. Guan P, et al,. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine 2011; 6: 965-974.
27. Lin J, et al,. Drug releasing behavior of hybrid micelles containing polypeptide triblock copolymer. Biomaterials 2009; 30: 108-117.
28. Higuchi T,. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145-1149.
29. Cheng T, et al,. Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 2007; 47: 2140-2148.